NCT01968889

Brief Summary

Critical illness neuromyopathy is a common disease acquired during ICU stay leading to a deep weakness involving the respiratory muscle work which result in a delayed weaning of mechanical ventilation. The main objective is to quantify the loss of diaphragm function by measuring the diaphragm force (using the non invasive method by phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion) in a selected population of patients with critical illness neuromyopathy (defined as a MRC score \< 48). The second end points are to evaluate its incidence, the consequences on the patients outcome (extubation success or failure; ICU stay) and to evaluate the relations between diaphragm function (twitch airway pressure during airway occlusion, maximal inspiratory pressure and diaphragm thickness evaluated by ultrasound) and peripheral limbs force (evaluated by the Medical Research Council - MRC score).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2013

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 24, 2013

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

December 3, 2014

Status Verified

December 1, 2014

Enrollment Period

6 months

First QC Date

August 19, 2013

Last Update Submit

December 2, 2014

Conditions

Keywords

Critical illness neuromyopathyDiaphragm dysfunctionMechanical ventilationWeaningUltrasound

Outcome Measures

Primary Outcomes (1)

  • Twitch tracheal pressure during airway occlusion (expressed in cmH2O)

    According the standard of care of weaning process; to evaluate the readiness of the patient to be extubated, the setting of the ventilator should be set at 7 cmH20 PRESSURE SUPPORT VENTILATION (PSV) level and zero end expiratory pressure (PEEP=0) during spontaneous mechanical ventilation to mimic the spontaneous breathing trial (SBT).

    At the begining of the spontaneous breathing trial

Secondary Outcomes (1)

  • extubation success (defined as no need reintubation during the 48h after extubation)

    Day 28 after ICU admission

Study Arms (1)

Critical illness neuromyopthy

Non invasive phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion

Other: Non invasive phrenic nerve stimulation

Interventions

Non invasive phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion

Critical illness neuromyopthy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients acquired weakness and neuromyopathy in ICU

You may qualify if:

  • MRC score \<48
  • ready for weaning from mechanical ventilation

You may not qualify if:

  • previous history of neuromyopathy
  • impossibility to perform a magnetic stimulation
  • cervical spine injury
  • bihemispheric or brain stem lesion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology & Critical Care, St Eloi University

Montpellier, 34000, France

Location

MeSH Terms

Conditions

Respiratory Paralysis

Condition Hierarchy (Ancestors)

Respiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Samir Jaber, MD PhD

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2013

First Posted

October 24, 2013

Study Start

May 1, 2013

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

December 3, 2014

Record last verified: 2014-12

Locations